Telomir Pharmaceuticals Gains Membership in Prestigious Russell Indexes
Tuesday, 2 July 2024, 12:30
Telomir Pharmaceuticals Included in Russell Indexes
TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) ( Telomir or the Company), a pre-clinical-stage pharmaceutical company focusing on innovative therapies, has been added to the Russell 3000 and Russell Microcap Indexes.
- This achievement reflects the growing recognition of Telomir within the investment community.
- The inclusion in these prestigious indexes is a testament to Telomir's strong performance and future growth prospects.
- Telomir Pharmaceuticals is now well-positioned among investors and stakeholders for potential investment opportunities.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.